Author

Genki Minegishi

Observed names: Minegishi, Genki, 峰岸, 元気, 峰岸元気

Institution: Meiji Pharmaceutical University

Observed institutions: Chiba University, Meiji Pharmaceutical University, Hoshi University, Taiho Pharmaceutical (Japan), Japan Organization of Occupational Health and Safety, National Institute of Health Sciences, Chromosome Engineering Research Center, Tottori University, Shimadzu (Japan), Kumamoto University

ORCID: 0009-0009-2421-0532

Observed ORCID: 0009-0009-2421-0532

OpenAlex ID: A5040278313

Deadenylase-dependent mRNA decay of GDF15 and FGF21 orchestrates food intake and energy expenditure

2022 · Sakie Katsumura, Nadeem Siddiqui, et al. · Cell Metabolism · 61

Characterization of P-Glycoprotein Humanized Mice Generated by Chromosome Engineering Technology: Its Utility for Prediction of Drug Distribution to the Brain in Humans

2018 · Yuki Yamasaki, Kaoru Kobayashi, et al. · Drug Metabolism and Disposition · 31

CYP3A4 Induction in the Liver and Intestine of Pregnane X Receptor/CYP3A-Humanized Mice: Approaches by Mass Spectrometry Imaging and Portal Blood Analysis

2019 · Kaoru Kobayashi, Jiro Kuze, et al. · Molecular Pharmacology · 18

Induction of hepatic CYP3A4 expression by cholesterol and cholic acid: Alterations of gene expression, microsomal activity, and pharmacokinetics

2024 · Genki Minegishi, Yuka Kobayashi, et al. · Pharmacology Research & Perspectives · 7

Comparison of the hepatic metabolism of triazolam in wild-type andCyp3a-knockout mice for understanding CYP3A-mediated metabolism inCYP3A-humanised mice in vivo

2018 · Genki Minegishi, Yasuhiro Kazuki, et al. · Xenobiotica · 7

Influence of MDR1 gene polymorphism (2677G>T) on expression and function of P-glycoprotein at the blood-brain barrier: utilizing novel P-glycoprotein humanized mice with mutation

2022 · Yuki Yamasaki, Takashi Moriwaki, et al. · Pharmacogenetics and Genomics · 6

Metabolic Disposition of Triazolam and Clobazam in Humanized CYP3A Mice with a Double-Knockout Background of Mouse Cyp2c and Cyp3a Genes

2022 · Kaoru Kobayashi, Genki Minegishi, et al. · Drug Metabolism and Disposition · 5

In vivo evaluation of intestinal human CYP3A inhibition by macrolide antibiotics in CYP3A-humanised mice

2021 · Genki Minegishi, Yasuhiro Kazuki, et al. · Xenobiotica · 4

Double-humanized Rats for CYP3A and PXR as an Improved Model for Analyzing Drug-drug Interactions Mediated by CYP3A4

2025 · Kaoru Kobayashi, Genki Minegishi, et al. · The AAPS Journal · 2

Evaluation of drug–drug interactions of traditional Japanese medicines (Hochuekkito, Goreisan and Ninjin’yoeito) in CYP3A-humanised mice

2026 · Mari Hida, Chiharu Sadakane, et al. · Figshare

Evaluation of drug–drug interactions of traditional Japanese medicines (Hochuekkito, Goreisan, and Ninjin’yoeito) in CYP3A-humanised mice

2026 · Mari Hida, Chiharu Sadakane, et al. · Xenobiotica

CYP3A5 polymorphism affects the disposition of tacrolimus and its metabolite in systemic circulation and peripheral tissues of mice introduced with the CYP3A5 gene

2026 · Genki Minegishi, Yuna Hiramatsu, et al. · Drug Metabolism and Disposition

CYP3Aヒト化マウスにおけるin vivoヒトCYP3A活性についての研究 : 薬物間相互作用および肝外代謝への応用

2022 · 峰岸, 元気 · Institutional Repositories DataBase (IRDB)

Inhibition effects of macrolide antibiotics on intestinal human CYP3A in CYP3A-humanized mice.

2020 · Genki Minegishi · The Pharmaceutical Society of Japan

LC-MS/MSを用いたマウスin vivoにおけるtriazolam代謝物の分析

2018 · 峰岸元気, 香月康宏, et al.

Works count: 17

Citation count: 141

H-index: 6

I10-index: 3